Not applicableStudy completedNCT01904942What this trial is testingStudy of Hepatocellular Carcinoma in Cirrhotic PatientsWho this might be right forHepatocellular Carcinoma Centre Hospitalier Universitaire Dijon 600
Not applicableLooking for participantsNCT07054086What this trial is testingPatient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer Shanghai Zhongshan Hospital 30
Not applicableUnknownNCT04773769What this trial is testingStudy of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade LymphomasWho this might be right forGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more Auxilio Mutuo Cancer Center 54
Large-scale testing (Phase 3)Study completedNCT01468883What this trial is testingThe Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive IrradiationWho this might be right forBreast Cancer National Cancer Institute (NCI) 256
Not applicableNot Yet RecruitingNCT06829641What this trial is testingClinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLCWho this might be right forNSCLC Stage IIIB, NSCLC Stage IIIC West China Hospital 200
Large-scale testing (Phase 3)Study completedNCT04543617What this trial is testingAtezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent ChemoradiotherapyWho this might be right forEsophageal Squamous Cell Carcinoma Hoffmann-La Roche 760
Large-scale testing (Phase 3)Looking for participantsNCT04996017What this trial is testingAtezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)Who this might be right forMesotheliomas Pleural Gruppo Oncologico Italiano di Ricerca Clinica 162
Testing effectiveness (Phase 2)UnknownNCT06235918What this trial is testingNeoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma Xiang Lu 30
Early research (Phase 1)Study completedNCT00356460What this trial is testingSafety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaWho this might be right forCarcinoma, Renal CellMelanoma Genzyme, a Sanofi Company 29
Not applicableNot Yet RecruitingNCT07368023What this trial is testingA Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaHepatocellular Carcinoma Non-resectable Ningbo Medical Center Lihuili Hospital 300
Testing effectiveness (Phase 2)UnknownNCT04974879What this trial is testingOsimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Qingdao Central Hospital 20
Early research (Phase 1)Active Not RecruitingNCT03478462What this trial is testingDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasWho this might be right forPediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more Cellectar Biosciences, Inc. 30
Not applicableUnknownNCT03940846What this trial is testingCT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor HistologyWho this might be right forNonsmall Cell Lung Cancer Maastricht University 650
Early research (Phase 1)Active Not RecruitingNCT04092270What this trial is testingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerWho this might be right forEndometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01305213What this trial is testingBevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma National Cancer Institute (NCI) 107
Early research (Phase 1)Looking for participantsNCT07443020What this trial is testingFast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary TumorsWho this might be right forMalignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07483359What this trial is testingConversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor ThrombusWho this might be right forHepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus First Hospital of China Medical University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779What this trial is testingErlotinib for Hepatocellular Carcinoma ChemopreventionWho this might be right forCirrhosis, LiverAdvanced Liver Fibrosis University of Texas Southwestern Medical Center 60
Not applicableActive Not RecruitingNCT01973179What this trial is testingRe-irradiation of Recurrent Head and Neck CancerWho this might be right forHead-and-neck Carcinoma Technische Universität Dresden 50
Testing effectiveness (Phase 2)Study completedNCT04059562What this trial is testingTrifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With CholangiocarcinomaWho this might be right forCholangiocarcinoma Heinrich-Heine University, Duesseldorf 28